Market Currents
Perrigo (PRGO +0.2%) announces that it nabbed final FDA approval for Desloratadine. The product...
-
Tuesday, December 27, 2011, 9:41 AM ETPerrigo (PRGO +0.2%) announces that it nabbed final FDA approval for Desloratadine. The product - set for commercial launch in July 2012 - is a generic version of Schering-Plough's Clarinex allergy relief treatment.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
